These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38128647)
1. Proteomic Analysis Revealed the Potential Role of MAGE-D2 in the Therapeutic Targeting of Triple-Negative Breast Cancer. Shi X; Liu C; Zheng W; Cao X; Li W; Zhang D; Zhu J; Zhang X; Chen Y Mol Cell Proteomics; 2024 Jan; 23(1):100703. PubMed ID: 38128647 [TBL] [Abstract][Full Text] [Related]
2. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9. Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906 [TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer. Lin Y; Lin L; Fu F; Wang C; Hu A; Xie J; Jiang M; Wang Z; Yang L; Guo R; Yang P; Shen H Breast Cancer Res Treat; 2021 Jan; 185(1):39-52. PubMed ID: 32920739 [TBL] [Abstract][Full Text] [Related]
4. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway. Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829 [TBL] [Abstract][Full Text] [Related]
5. Eugenol modulates the NOD1-NF-κB signaling pathway Shi X; Zhang W; Bao X; Liu X; Yang M; Yin C Front Endocrinol (Lausanne); 2023; 14():1136067. PubMed ID: 36923216 [TBL] [Abstract][Full Text] [Related]
6. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation. Velloso FJ; Campos AR; Sogayar MC; Correa RG BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886 [TBL] [Abstract][Full Text] [Related]
7. Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer. Cabezón T; Gromova I; Gromov P; Serizawa R; Timmermans Wielenga V; Kroman N; Celis JE; Moreira JM Mol Cell Proteomics; 2013 Feb; 12(2):381-94. PubMed ID: 23172894 [TBL] [Abstract][Full Text] [Related]
8. MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer. Xu JH; Zhao JX; Jiang MY; Yang LP; Sun ML; Wang HW Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3122-3129. PubMed ID: 32271430 [TBL] [Abstract][Full Text] [Related]
9. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563 [TBL] [Abstract][Full Text] [Related]
10. CircWAC induces chemotherapeutic resistance in triple-negative breast cancer by targeting miR-142, upregulating WWP1 and activating the PI3K/AKT pathway. Wang L; Zhou Y; Jiang L; Lu L; Dai T; Li A; Chen Y; Zhang L Mol Cancer; 2021 Mar; 20(1):43. PubMed ID: 33648498 [TBL] [Abstract][Full Text] [Related]
11. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway. Jiang S; Meng L; Chen X; Liu H; Zhang J; Chen F; Zheng J; Liu H; Wang F; Hu J; Li Z Exp Cell Res; 2020 Oct; 395(2):112191. PubMed ID: 32738346 [TBL] [Abstract][Full Text] [Related]
12. Myricetin-induced apoptosis in triple-negative breast cancer cells through inhibition of the PI3K/Akt/mTOR pathway. Sharma P; Khan MA; Najmi AK; Chaturvedi S; Akhtar M Med Oncol; 2022 Oct; 39(12):248. PubMed ID: 36209343 [TBL] [Abstract][Full Text] [Related]
13. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling. Cheng W; Liu D; Guo M; Li H; Wang Q Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453 [TBL] [Abstract][Full Text] [Related]
14. Quantitative Pattern of hPTMs by Mass Spectrometry-Based Proteomics with Implications for Triple-Negative Breast Cancer. Liu C; Xu M; Li W; Cao X; Wang Y; Chen H; Zhang T; Lu M; Xie H; Chen Y J Proteome Res; 2024 Apr; 23(4):1495-1505. PubMed ID: 38576392 [TBL] [Abstract][Full Text] [Related]
15. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers. Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051 [TBL] [Abstract][Full Text] [Related]
16. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway. Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857 [TBL] [Abstract][Full Text] [Related]
17. PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer. Guo F; Ma J; Li C; Liu S; Wu W; Li C; Wang J; Wang J; Li Z; Zhai J; Sun F; Zhou Y; Guo C; Qian H; Xu B Cell Death Dis; 2023 Apr; 14(4):272. PubMed ID: 37072408 [TBL] [Abstract][Full Text] [Related]
18. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer. Chan SH; Kuo WH; Wang LH J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106 [TBL] [Abstract][Full Text] [Related]
19. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer. Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446 [TBL] [Abstract][Full Text] [Related]
20. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer. Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]